News Focus
News Focus
Replies to #68010 on Biotech Values
icon url

bladerunner1717

10/30/08 9:31 PM

#68012 RE: DewDiligence #68010

Dew,

In your previous "musing on an HIV deal," you mentioned $500 million at the high end. Assuming that your high-end estimate is correct, how do you think this would break down in terms of upfront money, milestones and royalties? Thanks.


Bladerunner
icon url

DewDiligence

01/14/09 12:04 PM

#71487 RE: DewDiligence #68010

IDIX update from JPM conference:

JP Sommadossi implicitly confirmed that IDIX will get a nice chunk of up-front cash from the pending IDX899 partnership. He said that:

• Operating cash burn in 2009 will be about $66M (the same level as in 2008)
• No financing will be required to fund operations in 2009 (although the company might opt to raise money opportunistically)

Given that the cash balance at 12/31/08 was $46.3M, the above bullets imply a cash balance at the end of 2009 of negative $20M absent the cash haul from new deals.